A new study found that therapy dogs reduce anxiety in children visiting the emergency department, with both child-reported and parent-reported anxiety scores decreasing more in those who interacted with a...
A phase 3 study found that the 20-valent pneumococcal conjugate vaccine (PCV20) elicited strong immune responses across all 20 serotypes and had a safety profile comparable with PCV13.
This respiratory health update covers rising influenza deaths, the spread of new SARS-CoV-2 variants, shifting reinfection patterns, and cardiovascular risks in children
A phase 3 trial evaluating apremilast in children and adolescents with moderate-to-severe plaque psoriasis showed improvements in disease severity compared with placebo over 16 weeks.
The FDA has proposed new draft guidance to improve the accuracy of pulse oximeters across all skin tones, addressing long-standing concerns about potential disparities in performance.
Results from a recent randomized controlled trial shows that cognitive-behavioral stress management (CBSM) significantly reduces anxiety, depression, and post-traumatic stress disorder in parents of...
In this respiratory disease roundup, experts discuss the rising concerns over new cases of avian influenza in young people, the FDA's emergency approval of pemivibart monoclonal antibody for COVID-19, the...
Crinecerfont, a first-in-class therapy, improved androgen control and reduced reliance on high-dose glucocorticoids for patients with congenital adrenal hyperplasia.
In a study of more than 600,000 pediatric patients, researchers found a higher risk of type 2 diabetes within 6 months of a COVID-19 diagnosis compared with other respiratory infections, especially among...
A recent study found that single-dose intraoperative methadone reduced opioid consumption in children undergoing tonsillectomy compared with fentanyl, with no impact on postoperative pain scores or serious...
